Completed PHASE1 INTERVENTIONAL 2-arm NCT03996538

Vaccination Efficacy With Metformin in Older Adults (VEME)

Vaccination Efficacy With Metformin in Older Adults: A Pilot Study

Sponsor: UConn Health

Conditions Age-Related Immunodeficiency Aging Vaccine Response Impaired

Interventions Influenza Vaccine Metformin Hydrochloride Extended-Release Tablets

Updated 6 times since 2019 Last updated: Jul 22, 2020 Started: Jun 5, 2019 Primary completion: Feb 4, 2020 Completion: Feb 4, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Age-Related Immunodeficiency and Aging, this trial is completed. The trial is conducted by UConn Health and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Aug 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
May 2020 — Aug 2020 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting

▶ Show 1 earlier version

Jul 2019 — May 2020 [monthly]

Recruiting PHASE1

First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

UConn Health

Data source: UConn Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Farmington, United States